| Literature DB >> 35800399 |
Askale Gizaw1, Lencho Megersa Marami1, Ibsa Teshome1, Edilu Jorga Sarba2, Petros Admasu2, Dagmawit Atalel Babele1, Getachew Mulatu Dilba1, Wakuma Mitiku Bune1, Morka Dandecha Bayu1, Miressa Tadesse3, Kebede Abdisa2.
Abstract
Antimicrobial resistance to commercially available medications has become a global issue, yet there is still the possibility of developing new drugs from medicinal plants. As a result, the aims of the present study were to screen secondary metabolites and to evaluate in vitro antifungal activities of Brucea antidysenterica, Aloe vera, and Justicia schimperiana. After the plants were identified, their leaves were collected, washed, dried under the shade, pulverized, and extracted with methanol (99.8%) using the maceration technique. The presence of secondary metabolites in plant extracts was screened using various laboratory protocols. The antifungal activities of the plant extract against reference fungal strains of Candida albicans and Aspergillus niger at concentrations of 200, 100, and 50 mg/mL were assessed using the agar-well diffusion method. Ketoconazole (15 μg) was used as a positive control, while 5% dimethyl sulfoxide and/or 5% Tween 80 were used as negative controls. All tests were conducted in triplicate. Alkaloids, flavonoids, and phenols were secondary metabolites found in all plant extracts. The extract of leaves of B. antidysenterica and J. schimperiana formed a mean zone of inhibition of 15.5 ± 0.5 mm and 15.3 ± 0.58 mm, respectively, against Candida albicans at a concentration of 200 mg/mL, whereas extracts of A. vera leaves formed a 12.3 ± 0.58 mm inhibition zone only against Aspergillus niger at 200 mg/mL. In conclusion, the current study found that B. antidysenterica, A. vera, and J. schimperiana had antifungal activity. In addition, all these plants had a variety of secondary metabolites that possibly have antifungal activities. Studies on in vivo investigations and isolation of specific antifungal compounds from these medicinal plants are suggested.Entities:
Year: 2022 PMID: 35800399 PMCID: PMC9256430 DOI: 10.1155/2022/3299146
Source DB: PubMed Journal: Adv Pharmacol Pharm Sci ISSN: 2633-4690
Figure 1Map of the study area.
Results of percentage yield of plant crude extracts with methanol.
| Plant species | Weight of crude ( | Weight of sample ( | Yield (%) |
|---|---|---|---|
|
| 17 | 215 | 7.9 |
|
| 4.7 | 100 | 4.7 |
|
| 13 | 151 | 8.6 |
Results of preliminary phytochemical screening tests of methanolic plant extracts.
| Name of plants | Secondary metabolites | |||||
|---|---|---|---|---|---|---|
| Alkaloids | Phenols | Tannins | Saponins | Flavonoids | Glycosides | |
|
| ++ | + | − | ++ | + | + |
|
| + | + | + | − | + | − |
|
| + | + | + | + | + | − |
Notes: − absent, + slightly present, and ++ present.
Antifungal activity of methanolic extracts of leaves of plants against C. albicans and A. niger.
| Categories | Concentration (mg/mL) |
|
|
|---|---|---|---|
|
| 200 | 15.5 ± 0.5ab | 6.0 ± 0.0 |
|
| 100 | 13 ± 1.00a | 6.0 ± 0.0 |
|
| 50 | 11.3 ± 0.58a | 6.0 ± 0.0 |
|
| 200 | 6.0 ± 0.0 | 12.3 ± 0.58ac |
|
| 100 | 6.0 ± 0.0 | 11.7 ± 0.58a |
|
| 50 | 6.0 ± 0.0 | 10.3 ± 0.58a |
|
| 200 | 15.3 ± 0.58ac | 6.0 ± 0.0 |
|
| 100 | 13.3 ± 1.15ac | 6.0 ± 0.0 |
|
| 50 | 10.67 ± 0.58a | 6.0 ± 0.0 |
| Ketoconazole | 15 | 30.75 ± 1.70 | 23.5 ± 1.29 |
| DMSO | 5% | 6.0 ± 0.0 | — |
| Tween 80 | 5% | — | 6.0 ± 0.0 |
Values are expressed as the mean ± SD. aSignificance difference (p < 0.05) compared to negative control; bsignificance difference (p < 0.05) of 200 mg/mL compared to 50 mg/mL and 100 mg/mL; csignificance difference (p < 0.05) of 200 mg/mL and 100 mg/mL compared to 50 mg/mL. 6.0 ± 0.0 indicates that there is no inhibition zone created (it is considered as negative).